SACHDEV AMIT (EVP, CRO) sold 3.2% of their position (1.85K shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $897.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/26/2026ACC: 0000875320-26-000118
Officer· EVP, CRO
Since Jun 2018
-3.36K
Net shares
Net seller
$1.63M
Total sold
1
Open market trades
0B · 1S
2
Total transactions
3.36K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.52K
Price / share
$485.11
Trade value
$736.40K
% of position
2.6%
2/24/2026
58.93K→57.42K
Common Stock
Direct
Shares
−1.85K
Price / share
$486.35
Trade value
$897.80K
% of position
3.2%
2/25/2026
57.42K→55.57K
Total
Net shares
−3.36K
Net value
-$1.63M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2026 | F · Tax Withholding | −1.52K | $485.11 | $736.40K | 2.6% | 58.93K | 57.42K |
| Common Stock Direct | 2/25/2026 | S · Sale | −1.85K | $486.35 | $897.80K | 3.2% | 57.42K | 55.57K |
| Total | −3.36K | -$1.63M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned9.30K
Common Stock
IndirectShares owned882.00
Total
10.18K indirect10.18K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 9.30K | Indirect |
| Common Stock | 882.00 | Indirect |
| Total | 10.18K | 10.18K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported